Username Password
S&P 500: 1,351.68 Change: +0.14%

NOVO-NORDISK A S (NVO)

Overview
Price 135.02
Price Change Today 0.00 (0.00%)
P&P rating Rating: 3
Zacks Rank 2 - BUY
Open Price $0.00
Previous Close $135.02
Daily Range $0.00 - $0.00
52-Week Range $94.58 - $135.68
Volume 0
chart
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.
Other Resources for NVO
zacks.com
Commentary
Zacks Blog: Novo Nordisk Posts Solid 4Q
February 6, 2012
Zacks Blog: Third Time Lucky for Amylin's Bydureon
January 30, 2012
Zacks Blog: Bristol-Myers/AstraZeneca get CRL
January 19, 2012
Zacks Blog: Amylin Provides Strategy Update
January 10, 2012
Zacks Blog: Novo Files Degludec in Japan
December 27, 2011
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.
 
Brokerage Analyst Recommendations
4 Brokerage Firms Covering NVO
 
  
Strong Buy
2
Buy
0
Hold
2
Sell
0
Strong Sell
0
Average Broker Recommendation (ABR): 2
 
NVO Ratings:BUY  SELL  HOLD
NVO Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

10 Buy
1 Sell
 
Top Buy Analysis
BUY: NVO Rating: 3
Company: NOVO NORDISK A S
Points: 11.83
Start Price: $118.77
Start Date: 02/12/2011 4:12 PM
longtrade
longtrade
P&P Score: 97.71
Recs:
big in treatment of diabetes which is almost epidemic in U.S.

Comments: 0 | Comment


Top Sell Analysis
SELL: NVO Rating: 3
Company: NOVO NORDISK A S
Points: 0.10
Start Price: $134.50
Start Date: 02/07/2012 3:37 PM
JoeJustJoe
JoeJustJoe
P&P Score: 99.58
Recs:
134.45 showing as a chort term but not a LTCT...but thaaas "OK"...I'll take it! Trendlows at 122.10-120.45, 118.70-117.00, 99.51, n 93.00-92.00. 3J

Comments: 0 | Comment

Blog Posts
User User Score Date Title Comments Last Comment
Zacks_Analysts
0.00 02/06/12 Novo Nordisk Posts Solid 4Q - Analyst Blog 0
Zacks_Analysts
0.00 01/30/12 Third Time Lucky for Amylin's Bydureon - Analyst Blog 0
Zacks_Analysts
0.00 01/19/12 Bristol-Myers/AstraZeneca get CRL - Analyst Blog 0
Zacks_Analysts
0.00 01/10/12 Amylin Provides Strategy Update - Analyst Blog 0
Zacks_Analysts
0.00 12/27/11 Novo Files Degludec in Japan - Analyst Blog 0
Zacks_Analysts
0.00 12/09/11 Bristol-Myers Presents Data - Analyst Blog 0
Zacks_Analysts
0.00 11/17/11 Glaxo Candidate Disappoints - Analyst Blog 0
Zacks_Analysts
0.00 10/18/11 Earnings Preview: Eli Lilly - Analyst Blog 0
Zacks_Analysts
0.00 10/11/11 Novo Nordisk's Victoza Now in China - Analyst Blog 0
Zacks_Analysts
0.00 10/10/11 Novo Nordisk's Degludec Filed in US - Analyst Blog 0
Pages: [ 1 ]  2   3   4   5   6   7  >>
Commentary
SELL: NOVO NORDISK A S (NVO) Rating: 3
Start Price: $134.50
Points: +0.10
Created: 02/07/2012
134.45 showing as a chort term but not a LTCT...but thaaas "OK"...I'll take it! Trendlows at 122.10-120.45, 118.70-117.00, 99.51, n 93.00-92.00. 3J

Comments: 0 | Comment

Recs:
 
BUY: NOVO NORDISK A S (NVO) Rating: 3
Start Price: $124.57
Points: +4.76
Created: 03/01/2011
top telecom pick

Comments: 0 | Comment

Recs:
 
BUY: NOVO NORDISK A S (NVO) Rating: 3
Start Price: $118.77
Points: +11.83
Created: 02/12/2011
big in treatment of diabetes which is almost epidemic in U.S.

Comments: 0 | Comment

Recs:
 
BUY: NOVO NORDISK A S (NVO) Rating: 3
Start Price: $134.50
Points: -0.10
Created: 02/07/2012

Comments: 0 | Comment

vip vip
Recs:
 
BUY: NOVO NORDISK A S (NVO) Rating: 3
Start Price: $123.30
Points: +3.00
Created: 06/11/2011

Comments: 0 | Comment

dmb dmb
Recs:
 
BUY: NOVO NORDISK A S (NVO) Rating: 3
Start Price: $64.48
Points: +112.30
Created: 04/27/2008

Comments: 0 | Comment

Recs:
 
BUY: NOVO NORDISK A S (NVO) Rating: 3
Start Price: $24.31
Points: +462.55
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: NOVO NORDISK A S (NVO) Rating: 3
Start Price: $44.75
Points: +209.22
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: NOVO NORDISK A S (NVO) Rating: 3
Start Price: $32.00
Points: +329.27
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: NOVO NORDISK A S (NVO) Rating: 3
Start Price: $31.52
Points: +335.75
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
JoeJustJoe 99.58 SELL Six Months to a Year 02/07/2012 $134.50 $134.83
(+0.17%)
+0.25% +0.34% +0.10 view
vip 99.98 BUY One to Three Months 02/07/2012 $134.50 $134.83
(+0.17%)
+0.25% +0.34% -0.10
dmb 0.25 BUY One to Three Months 06/11/2011 $123.30 $134.83
(+0.17%)
+9.35% +6.35% +3.00
hofmann 2.38 BUY Week or Less 03/01/2011 $124.57 $134.83
(+0.17%)
+8.24% +3.47% +4.76 view
longtrade 97.71 BUY Three to Six Months 02/12/2011 $118.77 $134.83
(+0.17%)
+13.52% +1.70% +11.83 view
ryno8888 61.64 BUY Six Months to a Year 04/27/2008 $64.48 $134.83
(+0.17%)
+109.10% -3.20% +112.30
Bocomo 97.00 BUY Six Months to a Year 01/01/2008 $24.31 $134.83
(+0.17%)
+454.63% -7.92% +462.55
rolbou36 31.41 BUY Six Months to a Year 01/01/2008 $44.75 $134.83
(+0.17%)
+201.30% -7.92% +209.22
GC06 88.57 BUY Six Months to a Year 01/01/2008 $32.00 $134.83
(+0.17%)
+321.34% -7.92% +329.27
Kenn BUY Six Months to a Year 01/01/2008 $31.52 $134.83
(+0.17%)
+327.83% -7.92% +335.75
Pages: [ 1 ]  2  >>
Sponsored Links